Title:
ANTI-IL-25 ANTIBODIES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/102935
Kind Code:
A1
Abstract:
The present invention provides anti-IL-25 antibodies that are directed against (human) IL-25, nucleic acids that encode such antibodies, compositions, and in particular pharmaceutical compositions that comprise such antibodies; and uses of such antibodies and compositions.
Inventors:
GUO LI (CN)
SUN TIANTIAN (CN)
QI XIAOQU (CN)
DONG CHEN (CN)
SUN TIANTIAN (CN)
QI XIAOQU (CN)
DONG CHEN (CN)
Application Number:
PCT/CN2018/116170
Publication Date:
May 28, 2020
Filing Date:
November 19, 2018
Export Citation:
Assignee:
SUZHOU KANOVA BIOPHARMACEUTICAL CO LTD (CN)
BEIJING KANOVA BIOPHARMACEUTICAL CO LTD (CN)
BEIJING KANOVA BIOPHARMACEUTICAL CO LTD (CN)
International Classes:
A61K39/00; C07K16/24; A61K39/395; A61P11/06; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/00; C12N15/09; C12N15/13; C12N15/63
Domestic Patent References:
| WO2016049000A2 | 2016-03-31 | |||
| WO2011123507A1 | 2011-10-06 | |||
| WO2008129263A1 | 2008-10-30 |
Other References:
See also references of EP 3883965A4
Attorney, Agent or Firm:
CHINA SCIENCE PATENT & TRADEMARK AGENT LTD. (CN)
Download PDF: